Robert M. Harbos
FDA investigator
Appears on 1 document from 2014, mostly at sites in Indiana. Most often cites sampling and testing of in-process materials and drug products (21 CFR 211.110(a)).
- 1
- Documents on file
- 13.0
- Observations per 483
- 2014
- First seen
- 2014
- Most recent
What they cite most
From 13 observations- 21 CFR 211.110(a)Sampling and testing of in-process materials and drug products1
- 21 CFR 211.130Packaging and labeling operations1
- 21 CFR 211.142(b)Warehousing procedures1
- 21 CFR 211.160(b)(1)General requirements1
- 21 CFR 211.165(a)Testing and release for distribution1
- 21 CFR 211.166(a)Stability testing1
Activity by year
2014: 1
Where
Indiana 1
Is Robert M. Harbos coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2014-07-21 | Amended 483 American Family Pharmacy, LLCJul 21, 2014 · Indianapolis, Indiana | Indianapolis, Indiana | 13 |
About this profile
What does Robert M. Harbos inspect?
Robert M. Harbos appears on 1 document on file covering 1 site, mostly in Indiana.
What do they cite most often?
21 CFR 211.110(a) (sampling and testing of in-process materials and drug products), followed by 21 CFR 211.130 and 21 CFR 211.142(b).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Robert M. Harbos is dated Jul 21, 2014.